The Beat HLTH: Redefining Clinical Trials: Sasha Tyndale on Inclusive Research at AbbVie
About Sasha Tyndale:
Sasha Tyndale is a seasoned leader in the pharmaceutical industry with over 20 years of experience spanning oncology, immunology, neuroscience, and more. As Director of Diversity and Patient Inclusion at AbbVie, she drives patient-centric strategies and innovative clinical operations. With expertise in precision medicine and personalized healthcare, she collaborates cross-functionally to enhance patient engagement and future-proof organizations. Previously, she held key roles at PAREXEL and Johnson & Johnson, specializing in strategic patient recruitment and clinical innovation. Sasha holds a Master’s and Bachelor’s degree in English Literature from Rutgers University. Passionate about advancing equitable healthcare, she is committed to transforming research and improving patient outcomes.
Things You’ll Learn:
- AbbVie is making clinical trials more inclusive by ensuring they represent diverse populations affected by the diseases being studied.
- Through programs like ADMIRE, AbbVie is expanding research access by involving underrepresented healthcare providers in clinical research.
- AbbVie is simplifying participation in clinical trials by making study materials clearer and designing studies that minimize patient burden.
- Patient voices are essential in humanizing research, providing valuable insights into real-life disease challenges, and encouraging greater participation in clinical trials.
- AbbVie is taking bold action to challenge traditional research practices, collaborate with community partners, and improve healthcare access and representation.
- Educating individuals about clinical trials empowers communities to make informed decisions about participation in medical research.
Resources: